SuperworthPrecigen market cap PGEN
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $2.2B
- Highest close in our data
- $7.1B
- Jul 2015
Precigen is worth $2.2B at the close on Oct 23, 2026, at $6.19 a share.
That is up 72% over the last year and up 122% over five years.
Its highest close in our data was $7.1B in Jul 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2B | $1.2B | $3.1B | +51% |
| 2025 | $1.5B | $325.1M | $1.7B | +592% |
| 2024 | $212.7M | $197.8M | $435.6M | −36% |
| 2023 | $333.6M | $241.5M | $462.4M | +5% |
| 2022 | $316.4M | $257.5M | $667.8M | −59% |
| 2021 | $767M | $758.7M | $1.8B | −59% |
| 2020 | $1.9B | $341M | $1.9B | +103% |
| 2019 | $933.8M | $659.3M | $1.2B | +0% |
| 2018 | $933.1M | $929M | $2.5B | −33% |
| 2017 | $1.4B | $1.4B | $3.1B | −51% |
| 2016 | $2.9B | $2.8B | $4.4B | −18% |
| 2015 | $3.5B | $2.5B | $7.1B | +36% |
| 2014 | $2.5B | $1.5B | $3.4B | +26% |
| 2013 | $2B | $1.8B | $2.1B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Precigen's size, closest first, today.
| Company | Market cap |
|---|---|
| PGENPrecigen | $2.2B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| NRIXNurix Therapeutics | $2.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| Peer median | $2.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Precigen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.